Storm Therapeutics Limited
Research and experimental development on biotechnology · Waterbeach
ActiveUnited KingdomIncorporated 2015Private Limited Company
Documents & history
Available account evidence and business events. This is not a complete filing history or document library.
No electronic account filings
No extracted electronic accounts are available in our records.
Registered details
09553473- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 2015-04-21
- Jurisdiction
- —
- Registered office
- BUILDING 1000, CAMBRIDGE RESEARCH PARK, WATERBEACH, CAMBRIDGESHIRE, CB25 9PD, UNITED KINGDOM
Classification
1 SIC codes72110
Capital & company events
Reconstructed equity rounds and matched research funding.
Equity fundraising
6 SH01-derived rounds2026-03-19
£6,607,660 raised
£56,092,514 estimated post-money
2025-12-04
£8,159,250 raised
£47,799,707 estimated post-money
2024-12-11
£27,656,362 raised
£39,553,302 estimated post-money
2023-05-12
£9,142,544 raised
£80,886,598 estimated post-money
2022-07-29
£2,071,937 raised
£71,664,819 estimated post-money
2022-05-06
£25,779,747 raised
£58,997,060 estimated post-money
Research and innovation
7 matched grantsImmunology: Understanding the molecular and cellular basis of Immunity: Somatic Hypermutation and Affinity MaturationActiveBBSRC · Institute Project · 2024-03-31 – 2028-03-30 · with 3 other participants£850,305whole project
Immunology: Understanding the molecular and cellular basis of Immunity: Somatic Hypermutation and Affinity MaturationActive
BBSRC · Institute Project · 2024-03-31 – 2028-03-30 · with 3 other participants
£850,305
whole project
Development of RNA Methyltransferase Inhibitors as Therapeutics for SARS-CoV2 and Future Pandemic PreparednessLead
Innovate UK · Collaborative R&D · 2022-05-01 – 2023-10-31
£699,620
awarded
The function of the RNA methylome in animalsUKRI FLF · Fellowship · 2020-01-01 – 2024-02-29 · with 1 other participant£1,224,902whole project
The function of the RNA methylome in animals
UKRI FLF · Fellowship · 2020-01-01 – 2024-02-29 · with 1 other participant
£1,224,902
whole project
University Of East AnglialeadStorm Therapeutics Ltd
Unlocking high-throughput analysis within the RNA epigenetics domainBBSRC · Research Grant · 2019-03-31 – 2021-09-29 · with 1 other participant£202,097whole project
Unlocking high-throughput analysis within the RNA epigenetics domain
BBSRC · Research Grant · 2019-03-31 – 2021-09-29 · with 1 other participant
£202,097
whole project
University Of PortsmouthleadStorm Therapeutics Ltd
Unlocking high-throughput analysis within the RNA epigenetics domainBBSRC · Research Grant · 2019-03-31 – 2021-09-29 · with 1 other participant£202,097whole project
Unlocking high-throughput analysis within the RNA epigenetics domain
BBSRC · Research Grant · 2019-03-31 – 2021-09-29 · with 1 other participant
£202,097
whole project
University Of PortsmouthleadStorm Therapeutics Ltd
University of Cambridge and Storm Therapeutics LimitedInnovate UK · Knowledge Transfer Partnership · 2019-02-01 – 2022-01-31 · with 1 other participant
University of Cambridge and Storm Therapeutics Limited
Innovate UK · Knowledge Transfer Partnership · 2019-02-01 – 2022-01-31 · with 1 other participant
University of Cambridgelead£239,614
Storm Therapeutics Limited—
Regulating protein translation to protect from UV-induced damageMRC · Research Grant · 2015-09-30 – 2018-09-29 · with 4 other participants£542,642whole project
Regulating protein translation to protect from UV-induced damage
MRC · Research Grant · 2015-09-30 – 2018-09-29 · with 4 other participants
£542,642
whole project
University Of CambridgeleadMedical Research Council (MRC)Pasteur Institute, ParisStorm Therapeutics LtdWellcome Trust